Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Business (Details)

v3.21.2
Organization and Nature of Business (Details)
3 Months Ended 9 Months Ended
Dec. 21, 2020
USD ($)
shares
Dec. 16, 2020
D
$ / shares
shares
Sep. 30, 2021
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Sep. 30, 2021
USD ($)
segment
$ / shares
shares
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Subsidiary, Sale of Stock [Line Items]                      
Number of operating segments | segment                 1    
Warrants to purchase shares | shares   172,500 172,500           172,500    
Warrants exercise price | $ / shares   $ 12.50 $ 12.50           $ 12.50    
Warrants exercise price percentage of IPO Price   125.00%                  
Net loss     $ (4,109,982) $ (4,282,962) $ (3,056,033) $ (2,724,029) $ (654,585) $ (466,553) $ (11,448,977) $ (3,845,167)  
Net cash used in operating activities                 10,511,438 $ 1,608,834  
Accumulated deficit     $ 39,414,082           $ 39,414,082   $ 27,965,105
IPO                      
Subsidiary, Sale of Stock [Line Items]                      
Shares issued | shares 3,450,000 3,000,000                  
Share price | $ / shares   $ 10.00                  
Gross proceeds $ 34,500,000                    
Net proceeds $ 31,100,000                    
Underwriter option                      
Subsidiary, Sale of Stock [Line Items]                      
Shares issued | shares   450,000                  
Days to purchase additional shares granted to underwriters | D   45